These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 16777115)

  • 1. Platelet membrane CD154 and sCD154 in progressive peripheral arterial disease: a pilot study.
    Young RS; Naseem KM; Pasupathy S; Ahilathirunayagam S; Chaparala RP; Homer-Vanniasinkam S
    Atherosclerosis; 2007 Feb; 190(2):452-8. PubMed ID: 16777115
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Altered platelet reactivity in peripheral vascular disease complicated with elevated plasma homocysteine levels.
    Riba R; Nicolaou A; Troxler M; Homer-Vaniasinkam S; Naseem KM
    Atherosclerosis; 2004 Jul; 175(1):69-75. PubMed ID: 15186948
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Soluble CD40L in peripheral artery disease. Relationship with disease severity, platelet markers and the effects of angioplasty.
    Blann AD; Tan KT; Tayebjee MH; Davagnanam I; Moss M; Lip GY
    Thromb Haemost; 2005 Mar; 93(3):578-83. PubMed ID: 15735813
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Platelet activation increases with the severity of peripheral arterial disease: implications for clinical management.
    Rajagopalan S; Mckay I; Ford I; Bachoo P; Greaves M; Brittenden J
    J Vasc Surg; 2007 Sep; 46(3):485-90. PubMed ID: 17826235
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Platelet - derived CD154 antigen in patients with chronic kidney disease.
    Stępniewska J; Dołęgowska B; Chruściana M; Gołembiewska E; Malinowska-Jędraszczyk A; Marchelek-Myśliwiec M; Ciechanowski K
    Clin Biochem; 2016 Feb; 49(3):243-7. PubMed ID: 26549757
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Release of biologically active CD154 during collection and storage of platelet concentrates prepared for transfusion.
    Kaufman J; Spinelli SL; Schultz E; Blumberg N; Phipps RP
    J Thromb Haemost; 2007 Apr; 5(4):788-96. PubMed ID: 17403203
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enhanced levels of CD154 (CD40 ligand) on platelets in patients with chronic heart failure.
    Stumpf C; Lehner C; Eskafi S; Raaz D; Yilmaz A; Ropers S; Schmeisser A; Ludwig J; Daniel WG; Garlichs CD
    Eur J Heart Fail; 2003 Oct; 5(5):629-37. PubMed ID: 14607202
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Platelet microparticles and soluble P selectin in peripheral artery disease: relationship to extent of disease and platelet activation markers.
    Tan KT; Tayebjee MH; Lynd C; Blann AD; Lip GY
    Ann Med; 2005; 37(1):61-6. PubMed ID: 15902848
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Soluble CD154 in rheumatoid arthritis: elevated plasma levels in cases with vasculitis.
    Tamura N; Kobayashi S; Kato K; Bando H; Haruta K; Oyanagi M; Kuriyama M; Kipps TJ; Hashimoto H
    J Rheumatol; 2001 Dec; 28(12):2583-90. PubMed ID: 11764201
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of antiplatelet agents clopidogrel, aspirin, and cilostazol on circulating tissue factor procoagulant activity in patients with peripheral arterial disease.
    Rao AK; Vaidyula VR; Bagga S; Jalagadugula G; Gaughan J; Wilhite DB; Comerota AJ
    Thromb Haemost; 2006 Dec; 96(6):738-43. PubMed ID: 17139367
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Platelet monocyte aggregates and monocyte chemoattractant protein-1 are not inhibited by aspirin in critical limb ischaemia.
    Cleanthis M; Bhattacharya V; Smout J; Ashour H; Stansby G
    Eur J Vasc Endovasc Surg; 2007 Jun; 33(6):725-30. PubMed ID: 17296320
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Perioperative platelet and monocyte activation in patients with critical limb ischemia.
    Burdess A; Nimmo AF; Campbell N; Harding SA; Garden OJ; Dawson AR; Newby DE
    J Vasc Surg; 2010 Sep; 52(3):697-703. PubMed ID: 20816321
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The soluble CD40 ligand sCD154 in systemic lupus erythematosus.
    Kato K; Santana-Sahagún E; Rassenti LZ; Weisman MH; Tamura N; Kobayashi S; Hashimoto H; Kipps TJ
    J Clin Invest; 1999 Oct; 104(7):947-55. PubMed ID: 10510335
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Soluble CD154 is a unique predictor of nonfatal and fatal atherothrombotic events in patients who have end-stage renal disease and are on hemodialysis.
    Hocher B; Liefeldt L; Quaschning T; Kalk P; Ziebig R; Godes M; Relle K; Asmus G; Stasch JP
    J Am Soc Nephrol; 2007 Apr; 18(4):1323-30. PubMed ID: 17314326
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Platelet activation is increased in peripheral arterial disease.
    Cassar K; Bachoo P; Ford I; Greaves M; Brittenden J
    J Vasc Surg; 2003 Jul; 38(1):99-103. PubMed ID: 12844097
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relationship between metalloproteinase 2 and 9 concentrations and soluble CD154 expression in Iranian patients with multiple sclerosis.
    Sanchooli J; Ramroodi N; Sanadgol N; Sarabandi V; Ravan H; Rad RS
    Kaohsiung J Med Sci; 2014 May; 30(5):235-42. PubMed ID: 24751386
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Soluble CD154 is not associated with atherosclerosis in systemic lupus erythematosus.
    Kiani A; Mahoney JA; Petri M
    J Rheumatol; 2007 May; 34(5):969-72. PubMed ID: 17407217
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Flow cytometric assessment of platelet function in patients with peripheral arterial occlusive disease.
    Galt SW; McDaniel MD; Ault KA; Mitchell J; Cronenwett JL
    J Vasc Surg; 1991 Dec; 14(6):747-55; discussion 755-6. PubMed ID: 1720468
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The inflammatory action of CD40 ligand (CD154) expressed on activated human platelets is temporally limited by coexpressed CD40.
    Henn V; Steinbach S; Büchner K; Presek P; Kroczek RA
    Blood; 2001 Aug; 98(4):1047-54. PubMed ID: 11493450
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Markers of coagulation activation, endothelial stimulation and inflammation in patients with peripheral arterial disease.
    Cassar K; Bachoo P; Ford I; Greaves M; Brittenden J
    Eur J Vasc Endovasc Surg; 2005 Feb; 29(2):171-6. PubMed ID: 15649725
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.